Roche Licenses PI3K Biomarker from Qiagen

The company was granted a global co-exclusive license for the biomarker, which has been associated with several types of cancers, from Qiagen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.